Table of Content

1 Oral Sustained and Controlled Release Formulations Market Overview
1.1 Oral Sustained and Controlled Release Formulations Product Overview
1.2 Oral Sustained and Controlled Release Formulations Market Segment by Type
1.2.1 Skeleton Type
1.2.2 Membrane Controlled Type
1.2.3 Osmotic Pump Type
1.3 Global Oral Sustained and Controlled Release Formulations Market Size by Type
1.3.1 Global Oral Sustained and Controlled Release Formulations Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Sustained and Controlled Release Formulations Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oral Sustained and Controlled Release Formulations Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oral Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oral Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Breakdown by Type (2018-2024)
2 Global Oral Sustained and Controlled Release Formulations Market Competition by Company
2.1 Global Top Players by Oral Sustained and Controlled Release Formulations Sales (2018-2024)
2.2 Global Top Players by Oral Sustained and Controlled Release Formulations Revenue (2018-2024)
2.3 Global Top Players by Oral Sustained and Controlled Release Formulations Price (2018-2024)
2.4 Global Top Manufacturers Oral Sustained and Controlled Release Formulations Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Sustained and Controlled Release Formulations Market Competitive Situation and Trends
2.5.1 Oral Sustained and Controlled Release Formulations Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Sustained and Controlled Release Formulations Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Sustained and Controlled Release Formulations as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Sustained and Controlled Release Formulations Market
2.8 Key Manufacturers Oral Sustained and Controlled Release Formulations Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Sustained and Controlled Release Formulations Status and Outlook by Region
3.1 Global Oral Sustained and Controlled Release Formulations Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Sustained and Controlled Release Formulations Historic Market Size by Region
3.2.1 Global Oral Sustained and Controlled Release Formulations Sales in Volume by Region (2018-2024)
3.2.2 Global Oral Sustained and Controlled Release Formulations Sales in Value by Region (2018-2024)
3.2.3 Global Oral Sustained and Controlled Release Formulations Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oral Sustained and Controlled Release Formulations Forecasted Market Size by Region
3.3.1 Global Oral Sustained and Controlled Release Formulations Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Sustained and Controlled Release Formulations Sales in Value by Region (2024-2029)
3.3.3 Global Oral Sustained and Controlled Release Formulations Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Sustained and Controlled Release Formulations by Application
4.1 Oral Sustained and Controlled Release Formulations Market Segment by Application
4.1.1 Cardiovascular System Drugs
4.1.2 Nervous System Drugs
4.1.3 Digestive System and Metabolism
4.1.4 Other
4.2 Global Oral Sustained and Controlled Release Formulations Market Size by Application
4.2.1 Global Oral Sustained and Controlled Release Formulations Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Sustained and Controlled Release Formulations Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oral Sustained and Controlled Release Formulations Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oral Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oral Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Breakdown by Application (2018-2024)
5 North America Oral Sustained and Controlled Release Formulations by Country
5.1 North America Oral Sustained and Controlled Release Formulations Historic Market Size by Country
5.1.1 North America Oral Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
5.1.3 North America Oral Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
5.2 North America Oral Sustained and Controlled Release Formulations Forecasted Market Size by Country
5.2.1 North America Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
6 Europe Oral Sustained and Controlled Release Formulations by Country
6.1 Europe Oral Sustained and Controlled Release Formulations Historic Market Size by Country
6.1.1 Europe Oral Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
6.1.3 Europe Oral Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
6.2 Europe Oral Sustained and Controlled Release Formulations Forecasted Market Size by Country
6.2.1 Europe Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Sustained and Controlled Release Formulations by Region
7.1 Asia-Pacific Oral Sustained and Controlled Release Formulations Historic Market Size by Region
7.1.1 Asia-Pacific Oral Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oral Sustained and Controlled Release Formulations Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Sustained and Controlled Release Formulations Sales in Value by Region (2024-2029)
8 Latin America Oral Sustained and Controlled Release Formulations by Country
8.1 Latin America Oral Sustained and Controlled Release Formulations Historic Market Size by Country
8.1.1 Latin America Oral Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oral Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
8.2 Latin America Oral Sustained and Controlled Release Formulations Forecasted Market Size by Country
8.2.1 Latin America Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Sustained and Controlled Release Formulations by Country
9.1 Middle East and Africa Oral Sustained and Controlled Release Formulations Historic Market Size by Country
9.1.1 Middle East and Africa Oral Sustained and Controlled Release Formulations Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oral Sustained and Controlled Release Formulations Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Sustained and Controlled Release Formulations Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Humanwell Healthcare Co.,Ltd.
10.1.1 Humanwell Healthcare Co.,Ltd. Company Information
10.1.2 Humanwell Healthcare Co.,Ltd. Introduction and Business Overview
10.1.3 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.1.5 Humanwell Healthcare Co.,Ltd. Recent Development
10.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
10.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
10.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Introduction and Business Overview
10.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Development
10.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
10.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
10.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
10.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
10.4 Qilu Pharmaceutical Co Ltd
10.4.1 Qilu Pharmaceutical Co Ltd Company Information
10.4.2 Qilu Pharmaceutical Co Ltd Introduction and Business Overview
10.4.3 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Products Offered
10.4.5 Qilu Pharmaceutical Co Ltd Recent Development
10.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
10.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
10.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Introduction and Business Overview
10.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
10.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
10.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
10.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
10.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
10.7 PKU HealthCare Corp.,Ltd.
10.7.1 PKU HealthCare Corp.,Ltd. Company Information
10.7.2 PKU HealthCare Corp.,Ltd. Introduction and Business Overview
10.7.3 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.7.4 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.7.5 PKU HealthCare Corp.,Ltd. Recent Development
10.8 Overseas Pharmaceuticals, Ltd.
10.8.1 Overseas Pharmaceuticals, Ltd. Company Information
10.8.2 Overseas Pharmaceuticals, Ltd. Introduction and Business Overview
10.8.3 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Products Offered
10.8.5 Overseas Pharmaceuticals, Ltd. Recent Development
10.9 Novast Laboratories (China), LTD.
10.9.1 Novast Laboratories (China), LTD. Company Information
10.9.2 Novast Laboratories (China), LTD. Introduction and Business Overview
10.9.3 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Products Offered
10.9.5 Novast Laboratories (China), LTD. Recent Development
10.10 Catalent
10.10.1 Catalent Company Information
10.10.2 Catalent Introduction and Business Overview
10.10.3 Catalent Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Catalent Oral Sustained and Controlled Release Formulations Products Offered
10.10.5 Catalent Recent Development
10.11 AstraZeneca Plc
10.11.1 AstraZeneca Plc Company Information
10.11.2 AstraZeneca Plc Introduction and Business Overview
10.11.3 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.11.4 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Products Offered
10.11.5 AstraZeneca Plc Recent Development
10.12 Oakwood Labs
10.12.1 Oakwood Labs Company Information
10.12.2 Oakwood Labs Introduction and Business Overview
10.12.3 Oakwood Labs Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Oakwood Labs Oral Sustained and Controlled Release Formulations Products Offered
10.12.5 Oakwood Labs Recent Development
10.13 Ascendia Pharma
10.13.1 Ascendia Pharma Company Information
10.13.2 Ascendia Pharma Introduction and Business Overview
10.13.3 Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Ascendia Pharma Oral Sustained and Controlled Release Formulations Products Offered
10.13.5 Ascendia Pharma Recent Development
10.14 Colorcon
10.14.1 Colorcon Company Information
10.14.2 Colorcon Introduction and Business Overview
10.14.3 Colorcon Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Colorcon Oral Sustained and Controlled Release Formulations Products Offered
10.14.5 Colorcon Recent Development
10.15 Pfizer Inc.
10.15.1 Pfizer Inc. Company Information
10.15.2 Pfizer Inc. Introduction and Business Overview
10.15.3 Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pfizer Inc. Oral Sustained and Controlled Release Formulations Products Offered
10.15.5 Pfizer Inc. Recent Development
10.16 Mylan
10.16.1 Mylan Company Information
10.16.2 Mylan Introduction and Business Overview
10.16.3 Mylan Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Mylan Oral Sustained and Controlled Release Formulations Products Offered
10.16.5 Mylan Recent Development
10.17 Sandoz
10.17.1 Sandoz Company Information
10.17.2 Sandoz Introduction and Business Overview
10.17.3 Sandoz Oral Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Sandoz Oral Sustained and Controlled Release Formulations Products Offered
10.17.5 Sandoz Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Sustained and Controlled Release Formulations Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Sustained and Controlled Release Formulations Industrial Chain Analysis
11.4 Oral Sustained and Controlled Release Formulations Market Dynamics
11.4.1 Oral Sustained and Controlled Release Formulations Industry Trends
11.4.2 Oral Sustained and Controlled Release Formulations Market Drivers
11.4.3 Oral Sustained and Controlled Release Formulations Market Challenges
11.4.4 Oral Sustained and Controlled Release Formulations Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Sustained and Controlled Release Formulations Distributors
12.3 Oral Sustained and Controlled Release Formulations Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Skeleton Type
Table 2. Major Company of Membrane Controlled Type
Table 3. Major Company of Osmotic Pump Type
Table 4. Global Oral Sustained and Controlled Release Formulations Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 6. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US& Million)
Table 8. Global Oral Sustained and Controlled Release Formulations Market Share in Value by Type (2018-2024)
Table 9. Global Oral Sustained and Controlled Release Formulations Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 11. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type (2024-2029)
Table 14. Global Oral Sustained and Controlled Release Formulations Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 16. North America Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 18. Europe Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 22. Latin America Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Oral Sustained and Controlled Release Formulations Sales by Company (2018-2024) & (K Units)
Table 26. Global Oral Sustained and Controlled Release Formulations Sales Share by Company (2018-2024)
Table 27. Global Oral Sustained and Controlled Release Formulations Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Oral Sustained and Controlled Release Formulations Revenue Share by Company (2018-2024)
Table 29. Global Market Oral Sustained and Controlled Release Formulations Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Oral Sustained and Controlled Release Formulations Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Oral Sustained and Controlled Release Formulations Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Sustained and Controlled Release Formulations as of 2022)
Table 33. Date of Key Manufacturers Enter into Oral Sustained and Controlled Release Formulations Market
Table 34. Key Manufacturers Oral Sustained and Controlled Release Formulations Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Oral Sustained and Controlled Release Formulations Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 38. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2018-2024)
Table 41. Global Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 43. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2024-2029)
Table 46. Global Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Oral Sustained and Controlled Release Formulations Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 49. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application (2018-2024)
Table 52. Global Oral Sustained and Controlled Release Formulations Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 54. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application (2024-2029)
Table 57. Global Oral Sustained and Controlled Release Formulations Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 59. North America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 61. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 65. Latin America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 69. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 72. North America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 73. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 77. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 81. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Country (2024-2029)
Table 108. Humanwell Healthcare Co.,Ltd. Company Information
Table 109. Humanwell Healthcare Co.,Ltd. Introduction and Business Overview
Table 110. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 112. Humanwell Healthcare Co.,Ltd. Recent Development
Table 113. Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
Table 114. Nanjing Yiheng Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 115. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 117. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Development
Table 118. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 119. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Introduction and Business Overview
Table 120. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product
Table 122. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Development
Table 123. Qilu Pharmaceutical Co Ltd Company Information
Table 124. Qilu Pharmaceutical Co Ltd Introduction and Business Overview
Table 125. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product
Table 127. Qilu Pharmaceutical Co Ltd Recent Development
Table 128. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
Table 129. Shanghai Pharmaceuticals Holding Co.,Ltd. Introduction and Business Overview
Table 130. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 132. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
Table 133. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 134. Yangtze River Pharmaceutical (Group) Co., Ltd. Introduction and Business Overview
Table 135. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product
Table 137. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Development
Table 138. PKU HealthCare Corp.,Ltd. Company Information
Table 139. PKU HealthCare Corp.,Ltd. Introduction and Business Overview
Table 140. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product
Table 142. PKU HealthCare Corp.,Ltd. Recent Development
Table 143. Overseas Pharmaceuticals, Ltd. Company Information
Table 144. Overseas Pharmaceuticals, Ltd. Introduction and Business Overview
Table 145. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product
Table 147. Overseas Pharmaceuticals, Ltd. Recent Development
Table 148. Novast Laboratories (China), LTD. Company Information
Table 149. Novast Laboratories (China), LTD. Introduction and Business Overview
Table 150. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product
Table 152. Novast Laboratories (China), LTD. Recent Development
Table 153. Catalent Company Information
Table 154. Catalent Introduction and Business Overview
Table 155. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Catalent Oral Sustained and Controlled Release Formulations Product
Table 157. Catalent Recent Development
Table 158. AstraZeneca Plc Company Information
Table 159. AstraZeneca Plc Introduction and Business Overview
Table 160. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product
Table 162. AstraZeneca Plc Recent Development
Table 163. Oakwood Labs Company Information
Table 164. Oakwood Labs Introduction and Business Overview
Table 165. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Oakwood Labs Oral Sustained and Controlled Release Formulations Product
Table 167. Oakwood Labs Recent Development
Table 168. Ascendia Pharma Company Information
Table 169. Ascendia Pharma Introduction and Business Overview
Table 170. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product
Table 172. Ascendia Pharma Recent Development
Table 173. Colorcon Company Information
Table 174. Colorcon Introduction and Business Overview
Table 175. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Colorcon Oral Sustained and Controlled Release Formulations Product
Table 177. Colorcon Recent Development
Table 178. Pfizer Inc. Company Information
Table 179. Pfizer Inc. Introduction and Business Overview
Table 180. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product
Table 182. Pfizer Inc. Recent Development
Table 183. Mylan Company Information
Table 184. Mylan Introduction and Business Overview
Table 185. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Mylan Oral Sustained and Controlled Release Formulations Product
Table 187. Mylan Recent Development
Table 188. Sandoz Company Information
Table 189. Sandoz Introduction and Business Overview
Table 190. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Sandoz Oral Sustained and Controlled Release Formulations Product
Table 192. Sandoz Recent Development
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Oral Sustained and Controlled Release Formulations Market Trends
Table 196. Oral Sustained and Controlled Release Formulations Market Drivers
Table 197. Oral Sustained and Controlled Release Formulations Market Challenges
Table 198. Oral Sustained and Controlled Release Formulations Market Restraints
Table 199. Oral Sustained and Controlled Release Formulations Distributors List
Table 200. Oral Sustained and Controlled Release Formulations Downstream Customers
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Sustained and Controlled Release Formulations Product Picture
Figure 2. Global Oral Sustained and Controlled Release Formulations Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Sustained and Controlled Release Formulations Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Oral Sustained and Controlled Release Formulations Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Skeleton Type
Figure 6. Global Skeleton Type Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Membrane Controlled Type
Figure 8. Global Membrane Controlled Type Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Osmotic Pump Type
Figure 10. Global Osmotic Pump Type Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type in 2022 & 2029
Figure 13. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 14. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 15. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 16. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 19. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Sustained and Controlled Release Formulations Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Sustained and Controlled Release Formulations Revenue in 2022
Figure 25. Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Cardiovascular System Drugs
Figure 27. Global Cardiovascular System Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Nervous System Drugs
Figure 29. Global Nervous System Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Digestive System and Metabolism
Figure 31. Global Digestive System and Metabolism Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application in 2022 & 2029
Figure 36. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 37. North America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 38. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 39. Europe Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 42. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Oral Sustained and Controlled Release Formulations Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Oral Sustained and Controlled Release Formulations Manufacturing Cost Structure
Figure 47. Oral Sustained and Controlled Release Formulations Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed